TipRanks
Go Ultimate55% OFF

Medi Lifestyle Limited (Z4D) AI Stock Analysis

SG:Z4D

Medi Lifestyle Limited

(SGX:Z4D)

Select Model
Rating:41Neutral
Price Target:SGD 0.04â–¼(-6.82% Downside)
Action:reiterated
Date:10/16/26

The score is driven primarily by very weak financial performance (sharp TTM revenue contraction, negative margins, persistent cash burn, and negative equity). Technicals also lean bearish with the stock below key moving averages and negative MACD, while oversold readings provide only limited offset. Valuation offers little support given losses (negative P/E) and no dividend yield data.

Positive Factors
Improving cash burnImprovement in cash burn versus some prior annual periods indicates that resource consumption has moderated, even though cash flow remains negative. If sustained, this could reduce the pace of funding needs and provide a better base for operational stabilization.
Negative Factors
Sharp revenue contractionA 47.8% TTM revenue decline signals substantial deterioration in the company’s current sales base and weakens operating scale. Smaller revenue makes it harder to absorb fixed costs, rebuild margins, and generate the volume needed for a durable recovery.

Medi Lifestyle Limited (Z4D) vs. iShares MSCI Singapore ETF (EWS)

-200%0%200%400%600%800%SG:Z4D+350.00%EWS+12.23%Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
SGD 25.52M
Dividend Yield
―
Average Volume (3M)
10.82M
Price to Earnings (P/E)
-9.6
Beta (1Y)
0.62
Revenue Growth
-86.50%
EPS Growth
32.35%
Country
Singapore
Employees
156
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Medi Lifestyle Limited Business Overview & Revenue Model

Company Description

Medi Lifestyle Limited is an investment holding firm that offers a range of services, including placement solutions, across Malaysia, Singapore, and China. The company's operations are divided into three core segments: Healthcare, Outsourced Services...

Medi Lifestyle Limited Financial Statement Overview

Summary

Financials are under heavy pressure: TTM revenue fell 47.8%, profitability is deeply negative with gross margin turning negative, operating and free cash flow are negative across all periods, and shareholder equity is consistently negative—raising ongoing execution and financing risk.

Income Statement

9Very Negative

Balance Sheet

12Very Negative

Cash Flow

10Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue697.95K4.42M1.84M1.94M2.40M1.40M
Gross Profit-57.51K-54.02K-211.71K154.33K92.91K491.58K
EBITDA-3.71M-3.71M-4.69M-6.18M-3.49M-9.15M
Net Income-4.14M-3.86M-5.34M-7.19M-4.30M-23.72M
Balance Sheet
Total Assets5.10M845.76K1.86M811.50K2.18M4.03M
Cash, Cash Equivalents and Short-Term Investments4.73M261.30K1.07M106.11K510.06K1.22M
Total Debt1.24M1.20M1.57M3.84M3.53M4.96M
Total Liabilities12.67M6.33M3.45M10.03M10.89M9.96M
Stockholders Equity-7.57M-5.48M-1.59M-9.22M-8.71M-5.93M
Cash Flow
Free Cash Flow-2.40M-3.98M-6.54M-6.83M-2.31M-4.31M
Operating Cash Flow-2.39M-3.98M-6.54M-6.81M-2.12M-4.11M
Investing Cash Flow-4,000-3,8500-24.83K-191.16K-197.61K
Financing Cash Flow5.82M3.18M7.54M6.38M1.44M5.02M

Medi Lifestyle Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

SG:Z4D against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SG:OTXSG:OTX66NeutralSGD 26.91M7.9319.60%8.40%-3.11%-21.50%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SG:V8YSG:V8Y42NeutralSGD 12.59M-3.33118.31%―2.08%-50.00%
SG:Z4DSG:Z4D41NeutralSGD 33.56M-9.6470.68%―-86.50%32.35%

* Healthcare Sector Average

Performance Comparison

0%200%400%600%SG:Z4DSG:505SG:FRQSG:OTXSG:PRHJan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
SG:Z4D and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SG:Z4DMedi Lifestyle Limited0.040.03350.00%
SG:505Asiamedic Limited0.02-0.00-19.05%
SG:FRQSingapore Paincare Holdings Limited0.06-0.10-62.03%
SG:OTXMedinex Ltd.0.20-0.02-8.26%
SG:PRHLivingstone Health Holdings Limited0.02-0.01-20.69%

Medi Lifestyle Limited Corporate Events

Medi Lifestyle Details Use of S$8.6 Million Share Placement Proceeds

Sep 16, 2026

Medi Lifestyle Limited has completed a placement of 178,588,000 new shares, raising net proceeds of about S$8.59 million after expenses. The funds are earmarked for repaying a shareholder loan, supporting general working capital, and financing busine...

Medi Lifestyle Raises S$8.75 Million via Share Placement to Fund Growth

Aug 18, 2026

Medi Lifestyle Limited has launched a placement of 178,588,000 new ordinary shares at S$0.049 each to raise gross proceeds of about S$8.75 million. The new shares will represent roughly 23.95% of the enlarged share capital and are intended to broaden...

Medi Lifestyle Moves into Dental AI with Planned 60% Stake in EM2AI

Aug 16, 2026

Medi Lifestyle Limited has signed a non-binding term sheet to acquire a 60% stake in EM2AI Pte. Ltd. from Q & M Dental Group, marking its entry into technology-enabled healthcare. EM2AI is a Singapore-based medical technology company offering an...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 16, 2026